TERAFRONT
LIVE

Serial Number

79456087

Owner

TERAFRONT FARMATECH, S.L.

Filing Date

Jun 5, 2026

Add to watchlist:

No watchlists yet
View on USPTO

TERAFRONT Trademark

Serial Number: 79456087

TERAFRONT is a trademark filed by TERAFRONT FARMATECH, S.L. on June 5, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

TERAFRONT FARMATECH, S.L.

C/ Alfonso Gómez, 45A - 2ª planta

Entity Type: 98

Trademark Details

Filing Date

June 5, 2026

Registration Date

Not Registered

Goods & Services

Medical services; veterinary services; hygienic and beauty care services for persons; hygienic and beauty care services for animals; advisory and consultancy services relating to agriculture, horticulture and forestry; pharmaceutical advice; information and consultation services via the Internet regarding pharmaceutical products; drug testing service for medical use, namely drug analysis for medical diagnostic or treatment purposes; pharmacist services for filling prescriptions; medical analysis services relating to the treatment of people; consulting services in the field of pharmaceutical products.

Pharmaceutical products for medical and veterinary use, namely injectable pharmaceutical products and pharmaceutical products in solid form; hygienic and sanitary products for medical use; dietetic foods and nutritional supplements for medical or veterinary use, namely food for babies, nutritional supplements for humans, nutritional supplements for animals; plasters, namely adhesive bandages, medical dressings; materials for dental fillings; dental impression materials; all-purpose disinfectants; preparations for destroying vermin; fungicides for medical use; biological herbicides; antibiotics; pain relief medication; anesthetics for surgical and non-surgical use; amino acids for medical use; antiseptic preparations; anxiolytics; eye drops; digestives for pharmaceutical use; laxatives; prescription synthetic narcotics; chemical products for pharmaceutical and veterinary purposes; chemico-pharmaceutical products; restorative products for medical use; sedatives; soporifics in the form of tablets; pharmaceutical and medicinal products, namely medicinal serums; pharmaceutical and medicinal products, namely vaccines; syringes sold filled with injectable pharmaceutical products; unit-dose capsules filled with pharmaceutical products.

Scientific and technological services, specifically scientific testing and analysis of pharmaceutical and medical products in the pharmaceutical field; scientific research and design services in the field of pharmaceutical products; scientific research in the pharmaceutical field; industrial analysis and research services in the field of pharmaceutical and medical products; hardware and software design and development; research and development of new products for third parties; scientific research for new pharmaceutical products; development of pharmaceutical products; bacteriological research; biological research; geological research; chemical research; technical research in the field of pharmaceutical studies; technical research in the field of medical studies; conducting feasibility studies in the field of pharmaceutical and medical products; quality control services for goods and services; authentication services in the field of pharmaceutical and medical products; chemical analysis; testing of new products for third parties; testing of chemical products; scientific research consisting in conducting clinical trials for third parties; quality control for manufactured products; quality evaluation of pharmaceutical products.

Filing History

APPLICATION FILING RECEIPT MAILED
Aug 28, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 28, 2026 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 27, 2026 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 13, 2026 REPR